Evidence map›Paper›PMID 29248872›Full record

ArticleThe International journal on drug policy2018

The long tail of a demon drug: The 'bath salts' risk environment.

Luther Elliott, Ellen Benoit, Stephanie Campos, Eloise Dunlap

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Role of the media in promoting the dehumanization of people who use drugs.The American journal of drug and alcohol abuse · 2023
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luther ElliottNational Development and Research Institutes, Inc., 71 W. 23rd St., 4th Floor, New York, NY 10010, United States. Electronic address: Elliott@NDRI.org.
Ellen BenoitNational Development and Research Institutes, Inc., 71 W. 23rd St., 4th Floor, New York, NY 10010, United States.
Stephanie CamposNational Development and Research Institutes, Inc., 71 W. 23rd St., 4th Floor, New York, NY 10010, United States.
Eloise DunlapNational Development and Research Institutes, Inc., 71 W. 23rd St., 4th Floor, New York, NY 10010, United States.
National Development and Research Institutes · US

Funding

Bath Salts & the Illicit Drug Market: Use, Violence & Health ConsequencesR01DA035887 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI BENOIT, ELLEN, DUNLAP, ELOISE EMMA · 2014 to 2018
$2.7M
NIDA NIH HHS R01 DA035887
6 · The paper itself

Abstract

Using the case of synthetic cathinones (commonly referred to as 'bath salts' in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the 'long tail' of myriad lesser-known products and the diminished centrality of 'superstars' and 'hits'. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug 'analogues' legislation and greater involvement with NPS education and testing by harm reduction agencies.

Indexed as

Drug and Narcotic ControlHarm ReductionAlkaloidsHealth Risk BehaviorsHumansIllicit DrugsLegislation, DrugPsychotropic DrugsSubstance-Related DisordersUnited StatesAlkaloidsIllicit DrugsPsychotropic DrugsDrug marketsNovel psychoactive substancesRisk environmentSynthetic cathinones

Identifiers

PMID29248872
PMCPMC5762257
OpenAlexW2771486377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.